Inventor
KIM BO GYOU
KR13 patents
Patents
13 patentsUS8501917B2Aug 6, 2013
Anti c-Met antibody and uses thereof
SAMSUNG ELECTRONICS CO LTD6 citations83
US9808507B2Nov 7, 2017
Anti-c-Met/anti-Ang2 bispecific antibody
SAMSUNG ELECTRONICS CO LTD11 citations82
US9213031B2Dec 15, 2015
Use of Cbl as biomarker for identifying subject suitable for treatment with anti-c-Met antibody
SAMSUNG ELECTRONICS CO LTD7 citations82
US10246507B2Apr 2, 2019
Polypeptide, anti-VEGF antibody, and anti-c-Met/anti-VEGF bispecific antibodies comprising the same
SAMSUNG ELECTRONICS CO LTD6 citations72
US9535055B2Jan 3, 2017
Marker for determining effects of anti-c-Met antibody and method of determining effects of anti-c-Met antibody using the marker
SAMSUNG ELECTRONICS CO LTD4 citations72
US9233155B2Jan 12, 2016
Method of treating solid cancers using anti-c-Met antibody and sorafenib combination therapy
SAMSUNG ELECTRONICS CO LTD4 citations72
US9192666B2Nov 24, 2015
Method of treating cancer using anti-c-Met antibody and FGFR inhibitor combination therapy
SAMSUNG ELECTRONICS CO LTD4 citations72
US9567641B2Feb 14, 2017
Combination therapy for the treatment of cancer using an anti-C-met antibody
SAMSUNG ELECTRONICS CO LTD6 citations71
US9213032B2Dec 15, 2015
Use of LRIG1 as a biomarker for identifying a subject for application of anti-c-Met antibodies
SAMSUNG ELECTRONICS CO LTD2 citations62
US10578621B2Mar 3, 2020
Biomarker PNCK for predicting effect of a dual-targeting agent
SAMSUNG ELECTRONICS CO LTD0 citations51
US9850537B2Dec 26, 2017
Biomarker TFF1 for predicting effect of C-MET inhibitor
SAMSUNG ELECTRONICS CO LTD0 citations51
US9956244B2May 1, 2018
Biomarker Hsp90 for predicting effect of a c-Met inhibitor
SAMSUNG ELECTRONICS CO LTD0 citations40
US9943596B2Apr 17, 2018
Combination therapy using dual inhibitor of c-MET and EGFR and IGF-1R inhibitor
SAMSUNG ELECTRONICS CO LTD0 citations38